In 2014, a study demonstrated that ARAF was required for MAPK activation in a variety of cancer types (e.g., colorectal, pancreatic, and breast cancers) and further verified that ARAF enhanced the migration and invasive ability of these tumor cells [13]. Here, ARAF is linked to cancer.